Skip to main content

News & Articles

UTHealth Research

October 24, 2022
Written By: Roman Petrowski, McGovern Medical School | Updated: October 24, 2022
Recent research from the labs of Danielle Garsin, PhD, and Michael Lorenz, PhD, professors in the Department of Microbiology and Molecular Genetics with McGovern Medical School at UTHealth Houston, which identified a novel potential therapeutic against fungal infections, has been published in Nature Communications.
October 10, 2022
Written By: Halle Jones | Updated: October 10, 2022
Researchers at UTHealth Houston saw an increase in pediatric firearm-related injuries during the COVID-19 pandemic, despite also seeing a decrease in total pediatric emergency department (ED) visits over the same period, according to a poster presented at the 2022 American Academy of Pediatrics National Conference & Exhibition in Anaheim, California.
October 5, 2022
Written By: Halle Jones | Updated: October 5, 2022
Using a combination of biomarkers and mood assessments, researchers will study how pregnant women who are experiencing depression respond to different antidepressants in a clinical trial funded by a grant from the National Institutes of Health to UTHealth Houston.  Depression affects approximately 12% of pregnant women, according to the Centers for Disease Control and Prevention.
August 22, 2022
Written By: Aaron Zapata, Faillace Department of Psychiatry and Behavioral Sciences | Updated: August 22, 2022
A four-year, $2.25 million grant to identify a novel approach for facilitating smoking abstinence and limiting post-smoking cessation weight gain has been awarded to UTHealth Houston researcher Luba Yammine, PhD, by the National Institute on Drug Abuse (NIDA).
March 23, 2022
Written By: Jeannette Sanchez | Updated: March 23, 2022
The Cancer Prevention and Research Institute of Texas (CPRIT) awarded over $6 million to researchers with UTHealth Houston to aid in cancer prevention research. These awards will expand liver cancer prevention to persons experiencing homelessness, facilitate communication about the HPV vaccine, and find therapeutics that can help destroy gastrointestinal cancer cells.